U.S. Entertainment Stock News

If you are wondering whether American Express stock is pricing in too much optimism or leaving some value on the table, it helps to start by lining up its recent returns against what you are actually paying for the business. The stock last closed at US$309.70, after a 1.0% decline over the past week, a 6.1% decline over the past month, and a 16.9% decline year to date. However, the 1 year return sits at 9.0% and the 3 year and 5 year returns are 112.4% and 106.0% respectively. These moves...

Why Flywire’s Driftwood expansion matters for investors Flywire (FLYW) is back in focus after expanding its relationship with Driftwood Hospitality Management, extending its hospitality payment platform across nearly 90 US hotels that have already reported materially lower processing costs on earlier deployments. See our latest analysis for Flywire. Despite a modest 1-day share price return of 1.57% and some recent volatility over the past week, Flywire’s 30-day share price return of 18.04%...

USA Rare Earth (NasdaqGM:USAR) has secured a $19.3 million U.S. Department of Energy grant. The funding will support a pilot scale rare earth element separation project in the United States. The award is intended to advance domestic rare earth processing capacity and reduce reliance on foreign supply. For investors tracking USA Rare Earth at a share price of $24.29, this federal grant directly targets the company’s core focus on a domestic rare earth value chain. The stock has gained 71.7%...

Deckers Outdoor Corporation has now reported its fourth-quarter and full-year results to March 31, 2026, showing quarterly sales rising to US$1,119.37 million from US$1,021.78 million, while quarterly net income and diluted EPS eased to US$135.57 million and US$0.96 respectively. For the full year, sales increased to US$5.47 billion and net income reached US$1.02 billion, signaling that revenue growth continued even as the most recent quarter saw slightly lower earnings. With full-year...

Earlier this year, First Financial Bankshares reported quarterly results showing revenue up 12.5% year on year and tangible book value per share ahead of analyst expectations, while net interest income came in slightly below forecasts. The update highlighted how a relatively solid quarter for the bank sits against wider regional banking pressures such as fintech competition, deposit outflows, credit concerns, and rising regulatory costs. With shares posting a positive seven-day return, we’ll...

JD.com (NasdaqGS:JD) is rolling out its first fully AI integrated 618 Grand Promotion, applying AI across the campaign to support consumer experience and internal operations. The company is also introducing an official CHANEL Fragrance & Beauty flagship store on its platform, expanding its luxury and premium beauty offerings. Both developments are positioned around the upcoming 618 shopping festival, a key mid year promotional period in China. JD.com is a major Chinese e commerce company...

IonQ (IONQ) has attracted attention after recent trading, with the stock last closing at US$58.89. For readers tracking performance, returns over the past month and past 3 months have been strong. See our latest analysis for IonQ. The recent 1 day share price return of 12.24%, on top of a 30 day share price return of 27.25% and 90 day share price return of 84.61%, points to strong momentum. The 1 year total shareholder return of 28.61% sits against a very large 3 year total shareholder...

ACM Research (ACMR) has drawn fresh attention after reporting revenue up 34% year over year and reaffirming its 2026 guidance, while also highlighting strong shipment trends in electrochemical plating and advanced packaging tools. See our latest analysis for ACM Research. The recent revenue beat and reaffirmed 2026 outlook have coincided with brisk price momentum, with a 30 day share price return of 39.8% and a 1 year total shareholder return above 200%. This suggests sentiment has shifted...

nVent Electric plc recently declared a regular quarterly cash dividend of US$0.21 per share, payable on August 7, 2026, and authorized a new three-year share repurchase program of up to US$500 million alongside completing its prior buyback plan. Together, the renewed dividend commitment and fresh repurchase authorization highlight management’s emphasis on returning capital to shareholders while actively managing the company’s share count. We’ll now examine how this expanded share repurchase...

SentinelOne (S) is back in the spotlight after its Singularity Platform was added to AWS Security Hub Extended, coinciding with improving sentiment around AI software stocks and revenue growth projections ahead of upcoming earnings. See our latest analysis for SentinelOne. The 30 day share price return of 25.24% and 90 day share price return of 39.63% suggest momentum has picked up ahead of earnings, even though the 1 year total shareholder return declined 8.49%. If this renewed interest in...

Activist investors, including SOC Investment Group, Trillium Asset Management, and Mercy Investment Services, are urging shareholders to vote against selected Target board members at the June 10 annual meeting. The group cites years of alleged missteps and concerns over executive succession as Target rolls out merchandising changes, new brands, and supply chain shifts. The campaign focuses on board accountability at a time when Target is in the middle of a broad reset in its product, design,...

Wondering if Public Storage at about US$304.99 a share offers fair value or if the price is out of line with the fundamentals? This article breaks down what the market is currently implying. The stock has delivered a 0.6% return over the last week, is down 1.1% over the past month, and is up 18.0% year to date, with a 7.5% return over the past year that sits alongside 21.8% and 35.3% returns over the past 3 and 5 years. Recent coverage has focused on Public Storage as a large self storage...

Thermo Fisher Scientific (NYSE:TMO) has opened a new bioanalytical and biomarker laboratory in Gothenburg, Sweden. The facility is designed to support pharmaceutical and biotechnology companies across all stages of drug development. The lab is connected to Thermo Fisher Scientific's global network of drug development services. Thermo Fisher Scientific, trading at around $449.37, sits at the crossroads of tools, services, and outsourced support that many drug developers rely on. The stock is...

Earlier this week, Hut 8 Corp. agreed to invest about US$16,000,000 to expand West Feliciana Parish’s water system to support its River Bend AI data center campus, funding a new well, eight miles of water mains, and system upgrades that will be handed to the parish at no cost to taxpayers. This privately funded infrastructure build-out not only enables Hut 8’s closed-loop cooled AI facilities, but also boosts water capacity and reliability for more than 4,000 households and over 200 local...

Earlier in May 2026, Relay Therapeutics completed a US$275,000,004 follow-on equity offering at US$12 per share after releasing initial Phase 2 ReInspire data showing zovegalisib achieved a 60% volumetric response rate and broad symptom improvement in PIK3CA‑driven vascular anomalies with a safety profile supportive of chronic dosing. An interesting angle is that zovegalisib is being advanced simultaneously in rare vascular anomalies and in an ongoing Phase 3 program for metastatic breast...

Clinical update on TP-05 puts Tarsus Pharmaceuticals (TARS) in focus Tarsus Pharmaceuticals (TARS) recently updated investors on its ongoing Phase 2b trial of TP-05, an oral tablet being tested to help prevent Lyme disease in high risk individuals. See our latest analysis for Tarsus Pharmaceuticals. The recent TP-05 update comes as Tarsus trades at US$63.48, with the share price down 21.41% year to date but a 1 year total shareholder return of 47.73% and a very large 3 year total shareholder...

Recent performance snapshot Truist Financial (TFC) has drawn investor attention after its share price closed at US$47.89, with the stock down about 6% over the past month and roughly 8% over the past 3 months. See our latest analysis for Truist Financial. While the share price is down 6.2% over the past month and 8.5% over the past quarter, the 1 year total shareholder return of 26.8% and 3 year total shareholder return of 83.0% point to stronger longer term momentum. If Truist Financial has...

Oil price shock and HighPeak Energy's stock reaction HighPeak Energy (HPK) moved higher after crude oil prices climbed above $100 a barrel, as mounting geopolitical tensions and potential Strait of Hormuz disruptions fed through to oil linked equities and heightened day to day volatility. See our latest analysis for HighPeak Energy. Beyond the latest oil price shock, HighPeak Energy’s share price has shown strong short term momentum, with a 30 day share price return of 20.46% and a year to...

On 19 May 2026, ResMed and Oura announced a partnership that connects Oura Ring Gen3 and Ring 4 members in the U.S. to ResMed’s sleep education tools, assessments, and options to link with independent healthcare providers. This collaboration uniquely bridges consumer wearable sleep data with clinical sleep resources, aiming to help address undiagnosed conditions such as obstructive sleep apnea. Next, we’ll examine how integrating Oura’s consumer wearables data with ResMed’s clinical sleep...

Chubb (CB) has drawn fresh attention after shareholders approved a 5.2% dividend increase and a new US$7.5b share repurchase program, putting capital return policy firmly in focus for investors. See our latest analysis for Chubb. At a share price of US$330.26, Chubb’s recent news on dividends and buybacks comes after a steady year to date. A 6.51% year to date share price return and a 16.53% 1 year total shareholder return suggest that momentum has been building rather than fading. If you are...

Astrana Health (ASTH) has been in focus after Q1 earnings, where management highlighted strong revenue growth, increasing use of full risk contracts, and progress integrating the Prospect acquisition alongside its AI driven care platform. See our latest analysis for Astrana Health. Astrana Health's share price sits at $37.38 after a recent 1 day decline of 3.56% and 7 day fall of 4.55%. However, the 30 day share price return of 14.84% and 90 day gain of 88.22% highlight strong recent...

Nvidia’s recent US$10.4 million investment in Generate Biomedicines (GENB) has drawn fresh attention to the AI-focused biotech, as investors assess what this backing could mean for its drug development pipeline. See our latest analysis for Generate Biomedicines. The Nvidia investment comes after a volatile stretch for Generate Biomedicines, with a 1-day share price return of 7.37% to US$13.98, a 30-day share price return of 10.34% and a year to date share price return of 10.51%. This comes...

Cohu, Inc. recently reported that a semiconductor manufacturer placed multiple orders totaling approximately US$5,000,000 for its DiamondX test platform, which supports high‑current, ultra‑low resistance measurements and scalable multi‑site throughput for gallium nitride power devices in AI data center power architectures. This win highlights how Cohu is tying its advanced power test capabilities directly to the specific needs of AI data center power conversion, from AC‑DC front ends to...

Park National Corporation recently reported a past-quarter earnings beat and announced both a regular dividend increase and a special dividend for shareholders. This combination of stronger-than-expected results with an enhanced and one-off cash return highlights management’s focus on reinforcing shareholder income. We’ll now examine how Park National’s earnings surprise and special dividend shape its investment narrative for income-focused and quality-oriented investors. Uncover the next...